Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
61-75 of 437
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Project Oncology®Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS
Neil M. Iyengar, MD
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Urs Weber, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
- advertisement
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Project Oncology®Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Project Oncology®Post-BCMA Treatment Selection in R/R Multiple Myeloma
Steve Jackson, PharmD
Nisha Joseph, MD
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Project Oncology®6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Steve Jackson, PharmD
Lyudmila A. Bazhenova, MD
Assessing and Interpreting pCR in Perioperative NSCLC
Project Oncology®Assessing and Interpreting pCR in Perioperative NSCLC
Steve Jackson, PharmD
Alexander Spira, MD, PhD, FACP
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Project Oncology®Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Brian P. McDonough, MD, FAAFP
Andrew E. Hendifar, MD
- advertisement
Navigating Classification of High-Grade Neuroendocrine Neoplasms
Project Oncology®Navigating Classification of High-Grade Neuroendocrine Neoplasms
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Key Differences in Pulmonary and Extrapulmonary NEC Management
Project Oncology®Key Differences in Pulmonary and Extrapulmonary NEC Management
Alexandria May, PharmD, BCPS
Lowell B. Anthony, MD, FACP
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Project Oncology®Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD